This week the Update moves from its former strictly biweekly cadence to a weekly format; each issue will encompass a larger number of brief items. There may occasionally be longer features. Fear not, the frippery is here to stay. mRNA … Continue reading →
Three items of pandemic news: Long Covid in children; an FDA panel confirms an excess of heart inflammation following mRNA vaccination; and how the American tendency to individualism over collectivism hamstrung our pandemic response. Plus news briefs and a frippery. … Continue reading →
Herewith two items of recent pandemic news: Some clarity on long Covid and its relation to two known autonomic conditions; and watching for cases of heart inflammation in young men after mRNA vaccination. Plus news briefs and a frippery. Teens, … Continue reading →
Herewith three items of recent pandemic news: The toll of long Covid; Johnson & Johnson has no vaccine to ship; and the CDC’s unexpected new guidance on mask use in the vaccinated. Plus news briefs and a frippery. The CDC … Continue reading →
Belatedly, three items of recent pandemic news: Novavax and the EU; a detailed study of long haulers in the VA health care system; and the imminent authorization of Pfizer’s vaccine for young adolescents. Plus news briefs and a frippery. Authorization … Continue reading →
Herewith three items of pandemic news you may have missed recently: Disparate theories of long Covid; Europe locks in 1.8 billion Pfizer doses; and the troubles attendant upon Russia’s Sputnik V vaccine. Plus news briefs and a frippery. Russia’s Sputnik … Continue reading →
Three items of pandemic news you may have missed recently: Watching the virus evolve variants in a single human; a damning report on Emergent’s vaccine manufacturing plant; and the dimming prospects for herd immunity. Plus news briefs and a frippery. … Continue reading →
Herewith three items of pandemic news you may have missed recently: Evidence that post-infection people could need only one shot; asymptomatics and long Covid; and AstraZeneca on pause across Europe over safety concerns. Plus news briefs and a frippery. AstraZeneca … Continue reading →
Herewith three items of pandemic news you may have missed recently: Cautionary lessons from Brazil’s second wave in Manaus; CureVac’s manufacturing partnership with Bayer; and long Covid’s entanglement with autoantibodies. Plus news briefs and a frippery. Autoantibodies and long Covid … Continue reading →
Herewith three items of pandemic news you may have missed recently: How wearable computers could predict Covid-19; the complicated situation with autoantibodies; and the late-stage trial of German company CureVac’s vaccine candidate. Plus the accustomed frippery. CureVac’s candidate enters Phase … Continue reading →
Herewith three items of pandemic news you may have missed recently: troubling details on Long Covid; news from the treatment front; and Minnesota’s Covid notification app. Plus the accustomed frippery. Minnesota’s Covid notification app Yesterday I downloaded and installed COVIDaware … Continue reading →
Herewith three important items of Covid-19 news you may have missed this week: mounting evidence for aerosol transmission, the persistence of symptoms in children, and growing awareness of the mental health toll of the pandemic. Plus a frippery. Aerosol transmission … Continue reading →
